Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 23, 2025
Reporting period
Not applicable
Filed with the SEC
Oct 24, 2025
DirectorOther
Context
Classification
other
Code I — not an open-market trade
Planned / mechanical clue
Footnote references dividend reinvestment
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001022079-25-000228
Filed / recorded
Oct 24, 2025, 10:10 PM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
QUEST DIAGNOSTICS INC
Issuer CIK
1022079
Ticker
DGX
Reporting person
Gary M Pfeiffer
Relationship
Director
Security
Phantom Stock
Table
Derivative (Table II)
Transaction date
Oct 23, 2025
Transaction code
I
Shares / units
4,413.284
Price per share
$190.58
Acquired / disposed
Disposed (D)
Shares owned after
0
Ownership form
Direct
Amendment
No
Footnotes from the filing
This transaction constitutes an intra-plan transfer in the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors from the company stock fund to another investment option. The phantom common stock units were payable in cash and represented a like number of shares of the company's common stock.
The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.